Cornea and Corneal Implants Market to Reach US$ 420 Million by 2031

Photo of author

( — November 18, 2022) —

According to a new research study by Global Insight Services (GIS), the cornea and corneal implants market is expected to grow rapidly over the next 10 years to reach a value of more than the US $420 million by 2031.

A cornea transplant (keratoplasty) is a surgical procedure to substitute part of the cornea with corneal tissue from a donor. The cornea is the transparent, dome-shaped surface of the eye. It’s where light enters the eye and is a large part of the eye’s ability to see clearly. A cornea transplant may restore vision, reduce pain, and improve the appearance of a damaged or diseased cornea. Most cornea transplant procedures are successful. But cornea transplant carries a small risk of complications, like the rejection of the donor cornea.

Request Sample Pages of this Research Report: 

Cornea and Corneal Implants Market: Key Drivers

Increasing Prevalence of eye diseases

The number of people with major eye diseases is increasing worldwide, and vision loss is becoming a major public health concern. The growth in the aging population coupled with the increasing prevalence of chronic disorders like diabetes and hypertension have raised the prevalence of eye diseases such as diabetic retinopathy and ocular hypertension (glaucoma). The number of blind individuals or those affected with low vision is also expected to increase extensively. According to the Royal National Institute of Blind People (RNIB), in 2013, around 2 million people in the UK were living with vision loss, and this figure is likely to increase to 4.1 million by 2050. Presently, there are 146 million people worldwide with trachoma, of which 10 million suffer from trichiasis and need surgery to prevent corneal blindness and 4.9 million individuals are completely blind from trachomatous corneal scarring. Moreover, as per the “World Report on Vision 2019” by WHO, nearly 2.2 people worldwide have vision impairment or blindness. This figure includes several eye conditions that include moderate to severe distance vision impairment or blindness owing to unaddressed refractive errors (123.7 million) and presbyopia (1.8 billion, including both addressed and unaddressed presbyopia), age-related macular degeneration (10.4 million), cataract (65.2 million), corneal opacities (4.2 million), glaucoma (6.9 million), trachoma (2 million), diabetic retinopathy (3 million), and other causes (37.1 million), and people with mild vision impairment with unknown causes (188.5 million).

Shortage of corneal donors

There is a significant requirement for corneal donors across the globe, as approximately 10 million people need corneal transplants. Densely populated countries such as India suffer from a significant shortage of donor corneas, and there is a waiting period of more than six months for corneal transplants among patients suffering from corneal blindness. Approximately 6.8 million people in the country have poor vision in one eye, and nearly one million people have poor vision in both eyes due to corneal disorders. It was anticipated that by the end of 2020, India would suffer from 10.6 million cases of unilateral corneal blindness. In 2019, around 120,000 people were affected by corneal blindness. About 250,000 corneas are needed annually in the country; still, the total number of corneas donated each year is around 25,000. The high burden of corneal blindness, combined with a shortage of corneal donors, is likely to offer high-growth opportunities to manufacturers of corneal implants.

Report Findings

The human cornea segment is likely to hold a major market share during the forecast period.

The key factors boosting the growth of the market are rising awareness regarding corneal transplantation and eye tissue donations majorly in developing countries.

The penetrating keratoplasty segment is likely to hold the majority of the market share during the forecast period.

The factors boosting market growth are the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.

The fuchs’ dystrophy segment is likely to hold a major market share during the forecast period.

The key factors such as the increasing incidence of the disease and the growing awareness among people regarding early disease diagnosis are driving the market growth.

The hospitals & ambulatory surgical centers segment is likely to dominate the global cornea and corneal implant market during the forecast period.

The key factors such as rising incidences of corneal blindness coupled with increasing cases of trauma cases is propelling the growth of the global cornea and corneal implant market.

Competitive Landscape

The key players in the global cornea and corneal implants market are AJL Ophthalmic, CorneaGen Inc, CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH and EyeYon Medical among others.